about
Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teethHelicobacter pylori CagA triggers expression of the bactericidal lectin REG3γ via gastric STAT3 activationInhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivoImmunopathogenesis, loss of T cell tolerance and genetics of autoimmune gastritis.Lineage-specific RUNX3 hypomethylation marks the preneoplastic immune component of gastric cancer.Unicycler: Resolving bacterial genome assemblies from short and long sequencing readsAltered gp130 signalling ameliorates experimental colitis via myeloid cell-specific STAT3 activation and myeloid-derived suppressor cells.Differentiation of the Gastric Mucosa IV. Role of trefoil peptides and IL-6 cytokine family signaling in gastric homeostasis.Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression.Cytokine signalling via gp130 in gastric cancer.IL33 Is a Stomach Alarmin That Initiates a Skewed Th2 Response to Injury and Infection.Helicobacter pylori infection promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and humans.Targeting STAT3 in gastric cancer.Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.STAT3: a critical component in the response to Helicobacter pylori infection.Protease-activated Receptor 1 Plays a Proinflammatory Role in Colitis by Promoting Th17-related Immunity.IL-1RT1 signaling antagonizes IL-11 induced STAT3 dependent cardiac and antral stomach tumor development through myeloid cell enrichment.TFF2 deficiency exacerbates weight loss and alters immune cell and cytokine profiles in DSS colitis, and this cannot be rescued by wild-type bone marrow.The MUC1 mucin protects against Helicobacter pylori pathogenesis in mice by regulation of the NLRP3 inflammasome.RUNX3 methylation and anti-tumor immunity.IL-11 is a parietal cell cytokine that induces atrophic gastritisLoss of RegI in conjunction with gastrin deficiency in mice facilitates efficient gastric ulcer healing but is dispensable for hyperplasia and tumourigenesis.A33 antigen-deficient mice have defective colonic mucosal repair.Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130.Cytokine signalling by gp130 regulates gastric mucosal healing after ulceration and, indirectly, antral tumour progression.Myeloid regulatory cells: cross talk of innate and adaptive immunity to maintain the intestinal immune homeostasis in inflammatory bowel disease.Completing bacterial genome assemblies with multiplex MinION sequencing.Growth factors associated with gastric mucosal hypertrophy in autoimmune gastritis.Mice with a targeted disruption of the AE2 Cl-/HCO3- exchanger are achlorhydric.Antimicrobial resistant Klebsiella pneumoniae carriage and infection in specialized geriatric care wards linked to acquisition in the referring hospital.Abnormal Paneth cell granule dissolution and compromised resistance to bacterial colonization in the intestine of CF mice.Gastric achlorhydria in H/K-ATPase-deficient (Atp4a(-/-)) mice causes severe hyperplasia, mucocystic metaplasia and upregulation of growth factors.Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis.Evolution of carbapenem resistance in Acinetobacter baumannii during a prolonged infection.Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling.The interleukin-6 family cytokine interleukin-11 regulates homeostatic epithelial cell turnover and promotes gastric tumor development.Population genomics of hypervirulent Klebsiella pneumoniae clonal-group 23 reveals early emergence and rapid global disseminationRequirements for autoimmune responses to mouse gastric autoantigensAntimicrobial resistant Klebsiella pneumoniae carriage and infection in specialized geriatric care wards linked to acquisition in the referring hospital
P50
Q24312711-E91DFD93-7AEB-4199-9E0D-8D972BE41AE1Q34152656-3A5534A2-2B58-4638-94AD-AFEDBAD804D9Q35164307-8A805CA1-9C3E-4EA5-A52C-BD3FADF494BFQ35172066-D490872D-D693-4A4B-9FEE-90F66EB9DB60Q35463668-C923EFF5-CDC7-4C29-B322-102FBBC55281Q36395773-61A8A818-CE26-4E67-87AC-57955B9A672EQ36548697-284182A7-8A7D-4F60-BCF4-9B998DD60151Q36578929-0D042823-F6BA-4D15-88A2-35C792C3DABAQ36737879-3DD5DBB5-4FDB-40C4-AA81-25688890912CQ37576497-09E7AE1C-8346-48CF-8A67-1AF7AB1D1C53Q37634925-8A28554F-82A4-433A-BD8A-88D5C84347C4Q37674725-E7D9991A-F916-4E57-9539-FA362ED528C7Q38029729-6A870163-5669-4483-9E0E-CA71F19695C8Q38321420-CB75D5F5-C874-4544-8BE5-75067A1B1E26Q38579179-A6313C6B-8EC7-48C8-AAE0-C9C0ABBAC911Q38906013-CC525050-8735-4259-A08F-056559E3D1A9Q38926655-C34B8395-D21D-4638-81C2-07431603CD4EQ39111716-7F592AB1-9318-4544-9B11-03E24E9C0A0DQ41157817-6C4BEB75-8375-4999-874B-7677A81D2C6CQ42187008-8C1D038E-CE35-4BD6-93EF-4B1F629AF1D7Q42425803-FDC968BB-8E0D-4DA0-BB1E-37BA48E452A4Q43227819-BE845A09-04DA-4626-8426-3CFD11ABFE99Q43255084-BA33AF44-5926-4379-BF1D-B8DD5014E2B3Q44709460-67818C40-E7B4-4C25-9712-D0E3D7726BF3Q46190037-30A8F3CF-0AEF-4D85-A7CC-B5259141CCB6Q46538645-12D743B3-9FCD-4E2F-9B4B-00F088B7452DQ47139376-06884C53-112F-45F8-BC65-D856B09C9A1DQ47325067-CC5D4073-277D-4085-B719-8B9F5D912871Q47658185-10652A51-D7C7-4061-8790-6C6F1A83BD42Q50014955-F1F03FFC-A2A7-4BB7-8936-921FEA6048F8Q50101740-49DF80BE-C9F2-484D-A2AF-867D50277709Q50483649-5A684AE2-48D5-4404-8EF5-86892EE1FCB8Q51579099-E2A0020A-D3D4-476F-A3E5-D3705D9C84DEQ53594652-46D1F2F7-6F20-4308-BCF0-6752AD843E89Q53701660-972922EC-80FE-40E3-A74E-F34447DDC24CQ54652087-05B60015-8059-4EB2-9A96-0C55384C69A9Q54776327-F310CEEA-007A-4F10-A4EE-1EBC940D1205Q57176181-8EF6953B-49B3-4E91-BD18-2DF1E1F84548Q57240591-591B6ACA-82D7-4E33-BF31-6ACB94E6590EQ58002792-4EEA5D11-D0CB-4040-BD1E-7FACACACD194
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Louise M. Judd
@ast
Louise M. Judd
@en
Louise M. Judd
@es
Louise M. Judd
@nl
Louise M. Judd
@sl
type
label
Louise M. Judd
@ast
Louise M. Judd
@en
Louise M. Judd
@es
Louise M. Judd
@nl
Louise M. Judd
@sl
prefLabel
Louise M. Judd
@ast
Louise M. Judd
@en
Louise M. Judd
@es
Louise M. Judd
@nl
Louise M. Judd
@sl
P106
P1153
24590446200
P21
P31
P496
0000-0003-3613-4839